What does UNITED THERAPEUTICS Corp (UTHR) do?

UNITED THERAPEUTICS Corp (UTHR) is a publicly traded company in the Healthcare sector.

What sector does UTHR operate in?

UNITED THERAPEUTICS Corp operates in the Healthcare, specifically within the Pharmaceutical Preparations industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find UTHR earnings analysis?

AlphaOS publishes an earnings intelligence page for UNITED THERAPEUTICS Corp (UTHR) covering results, guidance context, and AI-assisted analysis. See /stocks/UTHR/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

UTHR

UNITED THERAPEUTICS Corp

Healthcare · Pharmaceutical Preparations

$475.45Sep 25, 2026

AI confidence 60% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

UNITED THERAPEUTICS Corp shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -2% YoY in Q2 FY2026.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -2% YoY in Q2 FY2026

Pipeline evidence · 22d ago

UTHR's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on UTHR.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full UTHR earnings analysis

Reported figures for UNITED THERAPEUTICS Corp — research only, not investment advice.

Revenue YoY: -1.9%
EPS YoY: +13.4%

Latest Intelligence

Updated September 25, 2026

What happened recently for UNITED THERAPEUTICS Corp (UTHR) — events, not interpretation.

Event: Reported Q2 2026 revenue -2% YoY.
Also: Last session September 25, 2026 at $475.45.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Industry & ETF context

Not yet mapped to an AlphaOS industry — run company activation to auto-map from sector keywords.
Held in 1 ETF(s) — largest weight IBB (1.84%).

Held in ETFsweight · est. sleeve dollars

IBB1.84%

Investment snapshot

UNITED THERAPEUTICS Corp

UTHR's opportunity score

Upgrade to Premium

Analysis confidence: 60%

UTHR's AI investment thesis

Upgrade to Premium for UTHR's full multi-agent investment thesis.

Create free account

Free accounts see more of this; Premium sees all of it.

60% confidence

Intelligence layer

Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity

PricesFinancialsFilingsFiling insightsEarningsEarnings AITranscriptsTechnicalOpportunityResearch

→Not yet mapped to an AlphaOS industry — run company activation to auto-map from sector keywords.
→Held in 1 ETF(s) — largest weight IBB (1.84%).

Strengthen intelligence

· Filing content needs parsing — re-ingest or wait for section extraction
· Run earnings AI analysis on latest quarter
· Fetch earnings call transcript for CEO commentary

Prior close

$475.45

Market cap

$20.39B

Profitable

Yes

Revenue $783.30M

Net income

$333.00M

FY Sep 9, 2026

Analyst ratings

Loading Wall Street consensus…

Earnings intelligence

Full earnings center

Loading earnings intelligence…

Technical intelligence

Building technical intelligence snapshot — check back shortly.

Loading market context…

Price & volume

0 trading days

No price history. Sync market data to load charts.

Filing insights

Loading SEC filing intelligence…

Competitive landscape

Recent SEC filings

Filings tab

No filings ingested yet.

UNITED THERAPEUTICS Corp (UTHR)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for UNITED THERAPEUTICS Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceutical Preparations
Market cap:: $20.39B
Revenue:: $783.30M

UTHR earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow UNITED THERAPEUTICS Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Connected companies and research pages from the AlphaOS knowledge graph.

Related stock research

Structured stock intelligence for companies connected to this research.

Opening stock page...

Fetching company snapshot, pricing, and intelligence.